1,055
Participants
Start Date
November 30, 1996
Primary Completion Date
May 31, 2012
Study Completion Date
May 31, 2012
5-fluorouracil
600 mg/m2 intravenously on day 1, every 21 days for six cycles
epirubicin
60 mg/m2 intravenously on day 1, every 21 days for six cyles
cyclophosphamide
600 mg/m2, intravenously on day 1, every 21 days for six cycles
epirubicin
90 mg/m2 on day 1, every 21 days for four cycles
paclitaxel
175 mg/m2, 3-hour infusion on day 1, every 21 days for four cycles
Antonio Durando, Torino
Saverio Danese, Torino
Federico Castiglione, Alba
Ornella Garrone, Cuneo
Lucia Del Mastro, Genoa
Giovanna Cavazzini, Mantova
Andrea Michelotti, Pisa
Tiziana Scotto, Sassari
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
OTHER